American coronavirus: Despite the case of the American Covid-19 cases, infections are still astonishingly high. This is what worries experts

American coronavirus: Despite the case of the American Covid-19 cases, infections are still astonishingly high. This is what worries experts

by

According to experts, however, for various reasons it is not time to abandon the safety measures.

According to the, more than 54 000 people are still admitted to hospital with the virus COVID tracking project. And more than 57,000 deaths in Covid-19 were recorded this month alone. The data from Johns Hopkins on Wednesday made California the first state to surpass 50,000 virus-related deaths, a cruel reminder of the brutal fight against the virus.

In fact, health officials are preparing for a possible third wave driven by a rapidly spreading variant first identified in the UK: B.1.1.7. Data from the CDC show that more than 1880 cases of the variant have been detected in the US, but scientists have warned that the number probably does not represent the total number of cases in the country.

“We can all wish it was the last wave,” White House senior adviser Andy Slavitt told the Covid-19 response team. ‘But we would not do our job if we were not really focused on the control measures for variants, if we were not really focused on how therapeutic agents could reduce the effects of the variants, how we could make sure if we had another wave, it feels different, ‘he said at a webinar hosted by the American Public Health Association.

To address this growing threat, the CDC is working with public and private laboratories to increase the capacity of genomic sequencing. And with the $ 200 million investment in the order of the Biden administration last week, the CDC hopes to quickly reach the goal of arranging 25,000 sample series a week, Walensky said.

Meanwhile, two separate teams of researchers said they found a worrying new variant in New York City and other areas in the Northeast that contains mutations that help it evade the body’s natural immune response, as well as the effects of monoclonal antibody treatments. .
And two studies that have come out soon raise concerns about a variant that scientists in California have been monitoring, suggesting that the variant may not only be more contagious, but can also cause serious illness.
Vanessa Garnes, Chief Supervisor of Nurse's Heart Medical Staffing in Columbus, Ohio, gives a Covid-19 test on February 21, 2021

A third vaccine for the US may only be a few days

But there is good news. The US may be just a few days away from getting another vaccine on the market.
Vaccine advisers from the Food and Drug Administration will meet Friday to determine if the Johnson & Johnson vaccine works and is safe. They will make a recommendation to the FDA and the agency can give the vaccine the green light as early as Friday or Saturday. Advisers to the CDC will then meet on Sunday to discuss recommendations regarding the possible roll-out of the vaccine – recommendations that should be formally accepted by the CDC.
The vaccination of Johnson & Johnson Covid-19 is safe and effective, the FDA analysis finds
And things are already looking good: in an analysis released Wednesday, the FDA said the Johnson & Johnson vaccine met the requirements for an emergency permit.

According to the analysis, the efficacy of the vaccine against moderate to severe / critical Covid-19 in all geographical areas was 66.9% at least 14 days after the single dose vaccination and 66.1% at least 28 days after the vaccination.

“No specific safety issues were identified in subgroup analyzes by age, race, ethnicity, medical comorbidities, or previous SARS-CoV-2 infection,” the analysis reads.

Millions more vaccine doses on the way

And while the U.S. has struggled with the shortage of supplies as it works to get Americans vaccinated, the numbers will increase in the coming months.

Questions remain about the implementation of J&J Covid-19 vaccine as the authorization decision approaches
Pfizer and Moderna – whose vaccines have already been authorized for emergency use – have promised to make a total of 220 million doses available for dispatch by March. Meanwhile, Johnson & Johnson has promised to make 20 million doses available at the same time if they obtain an emergency use authorization.
And a fourth Covid-19 vaccine could be available in the US in April – which could add millions more doses to the country’s stock by the end of that month.
President Joe Biden had earlier said that by the end of July, the US would have enough vaccines for 300 million Americans.

Other challenges facing national and state leaders are the issues of vaccination against vaccine and racial inequality.

Kentucky Gov. Andy Beshear on Wednesday announced an initiative in partnership with the Lexington Chapter of the National Association for the Advancement of Colored People (NAACP) to provide equitable access to vaccines and tackle reluctance.

According to a news release from the governor’s office, while black people make up about 8.4% of the state’s population, they make up about 4.6% of the people vaccinated so far.
Lack of equity within priority groups leaves Covid-19's most vulnerable without vaccine, analysis shows

Rev. Jim Thurman, president of the Lexington-Fayette County NAACP division, said he understood the reluctance in his community, saying he was initially reluctant to be vaccinated for historical reasons.

“I soon realized that it was safe and that you could not get the virus through the vaccine,” Thurman said. “COVID-19 has hit the African-American community and other communities of coloreds much harder. We need the vaccine.”

California officials meanwhile said they would make changes to the nationwide Covid-19 appointment system after access codes distributed to underserved communities were used by outsiders to secure the vaccine appointments.

Recent data shows that residents of Black and Latino collectively received 19% of the vaccine doses from the state, while they account for nearly 60% of the Covid-19 cases in California. In contrast, white residents received 32.7% of vaccine doses while accounting for approximately 20% of cases in the state.

A new initiative for long-distance riders

Meanwhile, an important announcement came this week for those who may still be dealing with the aftermath of Covid-19 long after their battle with the virus.

Nearly a third of people with 'soft' Covid-19 still struggle with symptoms months later, the study finds
The National Institutes of Health has announced a new initiative to study ‘Long Covid’ and ‘to identify the causes and ultimately ways of preventing and treating individuals who are ill with Covid-19 but who are not fully recovering’ over a period of several weeks, “NIH Director Dr. Francis Collins said in a statement.

The director said that a large number of patients ‘infected with the virus’ still experience symptoms since they recovered, which may include sleep disturbances, shortness of breath, fatigue and depression.

Clinics are emerging across the country for what a potential second pandemic calls: Long Covid

“While still being defined, these effects can be collectively referred to as post-acute sequencing of SARS-CoV-2 infection (PASC),” the statement said.

“We do not yet know the extent of the problem, but given the number of individuals of all ages who are or will be infected with SARS-CoV-2, the coronavirus that causes COVID-19 can have an impact on public health. be great, “it added.

The statement said that in December, Congress made $ 1.15 billion in funding over four years available to NIH to support research into the long-term effects of an infection.

Some of the questions the initiative hopes to answer, Collins said, include: what are the underlying biological causes of the long-term symptoms and what makes some people vulnerable to them, but not to others.

CNN’s Ben Tinker, Naomi Thomas, Amanda Watts, Jen Christensen, Maggie Fox, Cheri Mossburg and Christopher Rios contributed to this report.

.Source